Correction to Lancet Haematol 2025; 12: e248-57

No authors listed

Published Erratum

No authors listed. Lancet Haematol. 2025 May.

. 2025 May;12(5):e329.

doi: 10.1016/S2352-3026(25)00106-1. Epub 2025 Apr 14.

No abstract available

Erratum for

Crizanlizumab with or without hydroxyurea in patients with sickle cell disease (STAND): primary analyses from a placebo-controlled, randomised, double-blind, phase 3 trial.
Abboud MR, Cançado RD, De Montalembert M, Smith WR, Rimawi H, Voskaridou E, Güvenç B, Ataga KI, Keefe D, Grosch K, Watson J, Reshetnyak E, Nassin ML, Dei-Adomakoh Y. Abboud MR, et al. Lancet Haematol. 2025 Apr;12(4):e248-e257. doi: 10.1016/S2352-3026(24)00384-3. Epub 2025 Mar 12. Lancet Haematol. 2025. PMID: 40088922 Clinical Trial.